Home » Mylan Plans to Sell Generic EpiPen at Half Price
Mylan Plans to Sell Generic EpiPen at Half Price
In response to criticism surrounding the price of its EpiPen, Mylan plans to sell a generic version of its allergy treatment for half the price.
After four U.S. senators criticized the price hikes of Mylan’s EpiPen, the company announced plans to market a two-pack of generic auto-injectors for a list price of $300.
The list price of the company’s EpiPen injectors ballooned to $608 since 2008, when the product cost $100. The senators have questioned the company’s rationale for the price increase.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May